Poolbeg Pharma (POLB) Ord Shares
0.05p
(1.08%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.05p
(1.08%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.05p
(1.08%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
4.65p
4.80p
15.70p
£23.50 million
4.65p
4.60p
3.61p
n/a
0.00p (0.00%) Previous:
0.00p
393,318
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (4.50) | (4.78) |
| Adjusted EPS (p): | (0.79) | (0.94) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Poolbeg Pharma says Gilead in favour of its combination with Hookipa
10 January 2025 16:06
-
Poolbeg Pharma granted new US patent
20 November 2024 13:56
-
Poolbeg agrees 12-month option over potential Behcet's treatment
30 April 2024 16:43
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
22 January 2025 10:15
-
Form 8.5 (EPT/NON-RI)
22 January 2025 08:57
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
21 January 2025 11:37
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.